Skip to content

Protecting against HIV vaccine misinformation in South Africa

Protecting against HIV vaccine misinformation in South Africa

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202311613424063
Enrollment
133
Registered
2023-11-21
Start date
2023-10-16
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS

Interventions

Women 18 to 29 years

Sponsors

University of Pennsylvania
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Female Age 18-29 years Living in South Africa Able to read and understand English

Exclusion criteria

Exclusion criteria: Unwilling or unable to provide consent for study participation

Design outcomes

Primary

MeasureTime frame
The primary outcome will be participants’ rating of their level of concern about misinformation claims.

Secondary

MeasureTime frame
Identification of concerning misinformation claims.

Countries

South Africa

Contacts

Public ContactCandice Chetty Makkan

Senior Researcher

cchetty@heroza.org+27832892181

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026